Genetic variants associated with dengue hemorrhagic fever. A systematic review and meta-analysis.

Dengue virus Human leukocyte antigen Meta-analysis Odd ratio TNF toll-like receptors

Journal

Journal of infection and public health
ISSN: 1876-035X
Titre abrégé: J Infect Public Health
Pays: England
ID NLM: 101487384

Informations de publication

Date de publication:
03 Feb 2024
Historique:
received: 05 05 2023
revised: 25 01 2024
accepted: 01 02 2024
medline: 18 2 2024
pubmed: 18 2 2024
entrez: 18 2 2024
Statut: aheadofprint

Résumé

Dengue hemorrhagic fever (DHF) is a severe condition resulting from the dengue virus, with four serotypes known as DEN-1, DEN-2, DEN-3, and DEN-4. Genetic variations play a crucial role in influencing susceptibility to DHF. Therefore, this investigation conducted a meta-analysis to uncover genetic changes that might have remained undetected in individual studies due to small sample sizes or methodological differences. Among 2212 initially identified studies, 23 were deemed suitable for analysis based on PRISMA guidelines. Toll-like receptors (TLR) and CD209 showed significant association with DHF (odds ratios: TLR=0.56, CD209 =0.55), indicating protective effects. However, tumor necrosis factor (TNF) and human leukocyte antigen (HLA) did not exhibit a statistically significant relationship with DHF. This study emphasizes the relevance of TLR and CD209 in DHF susceptibility and resistance across diverse geographical locations.

Identifiants

pubmed: 38368646
pii: S1876-0341(24)00027-3
doi: 10.1016/j.jiph.2024.02.001
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

579-587

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Mohammed Kanan (M)

Department of Clinical Pharmacy, King Fahad Medical City, Riyadh 12211, Saudi Arabia.

Mohammed Naffaa (M)

Department of Forensic Toxicology, Poison Center, Arar, Northern Borders Region 73241, Saudi Arabia.

Ahmed Alanazi (A)

Poison Control and Forensic Chemistry Center, Arar, Northern Borders Region 73551, Saudi Arabia.

Faiz Nasser (F)

Department of Forensic Toxicology, Poison Center, Arar, Northern Borders Region 75861, Saudi Arabia.

Ahad Amer Alsaiari (AA)

Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.

Mazen Almehmadi (M)

Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.

Ali Assiry (A)

Department of Medical Supply, Mohayil Hospital, Health Affairs of Aseer, Abha 63711, Saudi Arabia.

Hisham Muzafar (H)

Department of Pharmacy, Jazan University Hospital, Jazan University, Jazan 82723, Saudi Arabia.

Hejab Katam (H)

Department of Radiology, Extended Care Hospital, Arar, Northern Borders Region 73551, Saudi Arabia.

Abdullah Arar (A)

Public Health Department, Northern Border Regional Lab & Blood Bank, Arar, Northern Borders Region 73241, Saudi Arabia.

Syed Mohammed Basheeruddin Asdaq (SMB)

Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Dariyah, 13713 Riyadh, Saudi Arabia.
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Northern Border University, Rafha 91911, Saudi Arabia.

Mohd Imran (M)

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Northern Border University, Rafha 91911, Saudi Arabia. Electronic address: imran.pchem@gmail.com.

Tafadzwa Dzinamarira (T)

School of Health Systems and Public Health, University of Pretoria, Pretoria 0002, South Africa; ICAP, Columbia University, P.O. Box 28, Harare, Zimbabwe. Electronic address: u19395419@up.ac.za.

Classifications MeSH